Latest Breaking News On - லியோனார்ட் மஜுர் - Page 1 : comparemela.com

Share: Myron Holubiak, president and CEO of Citius Pharmaceuticals Inc (NASDAQ: CTXR), appeared Thursday at Benzinga s Global Small Cap Conference for an exclusive interview. The name Citius Pharmaceuticals comes from the Olympic motto Citius, Altius, Fortius, which is Latin for Faster, Higher, Stronger, Holubiak told Benzinga.  The Citius CEO told Benzinga that he and executive chairman Leonard Mazur have collectively invested $26 million in the company. Mino-Lok: Citius lead asset Mino-Lok is an antibiotic lock solution drug that is used in the treatment of catheter-related bloodstream infections. Mino-Lok is in late stage three clinical studies, Holubiak said. When a catheter gets infected, the current solution is the costly and painful procedure of removing and replacing it. Complications with the remove and replace procedure include infection, thrombosis, occlusion and mechanical complications, he said, adding that removal and reinsertion causes phys

Myron holubiakLeonard mazurCitius pharmaceuticals incCitius pharmaceuticalsGlobal small cap conferenceAddressable marketலியோனார்ட் மஜுர்உலகளாவிய சிறிய தொப்பி மாநாடு